2019-NCoV: What every neurologist should know?

Mahajan, Nitika; Singla, Monika; Singh, Balveen; Sajja, Venkatesh; Bansal, Parth; Paul, Birinder S; Goel, Parveen; Midha, Rahul; Bansal, R.K.; Singh, Gagandeep

doi:10.4103/aian.aian_210_20

Cited by 7 publications

(4 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These are particularly common among patients with pre-existing comorbidities (hypertension, obesity, diabetes, and others; see Table 3 ) or those with severe COVID-19. [ 2 3 4 5 ] While in most patients, neurological effects are seen concurrently or within a few days of the classical COVID-19 symptoms, in some the neurological features predate or develop significantly later than the initial febrile illness. [ 3 6 7 ] Some neurological issues may persist beyond the resolution of the infection and, it is feared, that COVID-19 may leave the patients susceptible to delayed-onset neurological disorders.…”

Section: N Eurological E Ffects Of mentioning

confidence: 99%

Neurology and COVID-19: Acting now. Preparing for future

Aggarwal¹,

Singhal²,

Bhatt³

2020

Ann Indian Acad Neurol

View full text Add to dashboard Cite

COVID-19 has a wide-ranging and multimodal neurological impact. First, several neurological symptoms and complications are commonly observed in patients with COVID-19. Second, medications and vaccinations used to counter the disease can have secondary neurological effects. Third, patients with pre-existing neurological disorders bear an increased health-risk due to COVID-19. And finally, the pandemic has disrupted the delivery of neurological and vaccination services, and associated educational and research programs. In this article we review the various channels through which the pandemic is known or projected to effect individual patients or the practice of neurology. We also provide recommendations to manage its immediate effects and prepare for the longer-term fall-out.

show abstract

Section: N Eurological E Ffects Of mentioning

confidence: 99%

Neurology and COVID-19: Acting now. Preparing for future

Aggarwal¹,

Singhal²,

Bhatt³

2020

Ann Indian Acad Neurol

View full text Add to dashboard Cite

show abstract

“…At present, there is no information to suggest that either epilepsy or its treatment (antiepileptic drugs) will in any way make a person susceptible to COVID-19. [ 5 6 ] Indeed, there is no suggestion that people with epilepsy have any special immune vulnerability either to COVID-19. However, the stress of the pandemic can induce sleep deprivation and lifestyle changes and can make a person prone to increase in the frequency of existing seizures.…”

Section: Introductionmentioning

confidence: 99%

Impact of COVID-19 on People Suffering with Epilepsy

Sureka¹,

Gaur²,

Gupta³

2021

Annals of Indian Academy of Neurology

View full text Add to dashboard Cite

Background: Epilepsy is one of the most common problems in neurology clinical practice and currently we are in the midst of the coronavirus outbreak. The coronavirus pandemic is an epidemiological and psychological crisis, which is likely to affect persons with epilepsy. Objectives: This study was designed to evaluate the impact of COVID-19 pandemic on patients with epilepsy and effects on their mental health. Materials and Methods: This was a cross-sectional web-based survey carried out at the department of Neurology at a tertiary care hospital. A questionnaire was designed in the local language using Google Forms to assess basic knowledge regarding epilepsy, coronavirus, effects of COVID-19 and lockdown on epileptic patients and also effects on their mental health. The link to the online survey was distributed via WhatsApp messenger to epilepsy patients. Results: One hundred fifty-six cases were enrolled with 69.1% were below 34 years of age and male: female ratio was 1.2:1. Only 34.3% of the participants were employed and 50% of patients had an income of less than Rs. 3000 per month. Of the patients enrolled, 20.5% reported the “devil” and superstitions as a cause of epilepsy and only 10% of patients thought that tantric (holy priest) could treat the disease better than doctors. 53.8% of patients worried about getting COVID-19 and could not stop thoughts about being infected by coronavirus bothering them. 30.3% patients had increased seizure frequency during COVID-19 pandemic, of which the most common reason was that they forgot to take regular antiepileptic drugs (22.7%) or they had faced difficulty in obtaining medicine due to lockdown (12.1%). During the pandemic, 17% of patients reported depression symptoms and another 21% reported anxiety symptoms. Conclusion: The current COVID-19 pandemic negatively affected patients with epilepsy and increased seizure frequency, depression, anxiety, unemployment, and financial difficulty in obtaining medication.

show abstract

“…We believe it is acceptable to say that patients who have no chance of survival must receive psychological support and palliative care. However, according to the views of specialists already published since the start of the pandemic, 19,20 hospital access for people with chronic neurodegenerative conditions such as dementia, more at risk of serious consequences from the infection, cannot be postponed.…”

Section: Resultsmentioning

confidence: 99%

Dementia in the era of COVID‐19. Some considerations and ethical issues

2021

View full text Add to dashboard Cite

Living with dementia at any time brings everyday challenges for the patient and those around him/her. The Covid‐19 pandemic is making daily life harder. We aim to describe the problems of people with dementia during the time of such a pandemic and address the issue of their access to intensive care units. A systematic literature search (Cochrane Library (advanced search), and PubMed) was performed (for items up to 19 August 2020) using the following terms: ‘COVID‐19’, ‘dementia’, and ‘intensive care unit’. Studies were independently evaluated and selected for potential analysis. Five of 35 articles initially selected met the inclusion criteria. An additional Google Scholar search identified some striking statements from relevant authorities or scientists about the difficulty of living with dementia in the era of COVID‐19, and were also reported. To summarize, dementia‐related behaviours, increased age, and comorbid health conditions may increase the risk of contracting the virus. People with dementia in their own homes may already feel isolated, and additional rules for self‐isolation may make this worse. As COVID‐19 is spreading worldwide, governments and health authorities should devise better criteria for accessing intensive care units and allocating ventilators. If someone is given preference for medical care, it should be because that person has a better short‐term prognosis, not simply because that person is younger than someone else.

show abstract

2019-NCoV: What every neurologist should know?

Cited by 7 publications

References 14 publications

Neurology and COVID-19: Acting now. Preparing for future

Neurology and COVID-19: Acting now. Preparing for future

Impact of COVID-19 on People Suffering with Epilepsy

Dementia in the era of COVID‐19. Some considerations and ethical issues

Contact Info

Product

Resources

About